Cytadren
Brand names,
Cytadren
Analogs
Cytadren
Brand Names Mixture
Cytadren
Chemical_Formula
C13H16N2O2
Cytadren
RX_link
http://www.rxlist.com/cgi/generic3/cytadren.htm
Cytadren
fda sheet
Cytadren
msds (material safety sheet)
Cytadren
Synthesis Reference
Hoffmann, Urech, U.S. pat. 2,848,455 (1958 to Ciba)
Cytadren
Molecular Weight
232.278 g/mol
Cytadren
Melting Point
149-150 oC
Cytadren
H2O Solubility
Practically insoluble in water
Cytadren
State
Solid
Cytadren
LogP
2.029
Cytadren
Dosage Forms
Tablet (250 mg)
Cytadren
Indication
For the suppression of adrenal function in selected patients with Cushing's syndrome, malignant neoplasm of the female breast, and carcinoma in situ of the breast.
Cytadren
Pharmacology
Aminoglutethimide inhibits the enzymatic conversion of cholesterol to D5-pregnenolone, resulting in a decrease in the production of adrenal glucocorticoids, mineralocorticoids, estrogens, and androgens.
Cytadren
Absorption
Rapidly and completely absorbed from gastrointestinal tract. The bioavailability of tablets is equivalent to equal doses given as a solution.
Cytadren
side effects and Toxicity
Oral LD50s (mg/kg): rats, 1800; dogs, >100. Intravenous LD50s (mg/kg): rats, 156; dogs, >100. Symptoms of overdose include respiratory depression, hypoventilation, hypotension, hypovolemic shock due to dehydration, somnolence, lethargy, coma, ataxia, dizziness, fatigue, nausea, and vomiting.
Cytadren
Patient Information
Cytadren
Organisms Affected
Humans and other mammals